collaboration

Texas Research Institute, TGen, OncoHost Partner to ID Lung Cancer Resistance Mechanisms

Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test

Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform

Genentech Offers Kronos Bio up to $554M in Deal to Discover Drugs Against Transcription Factors

GreenLight Biosciences, EpiVax Therapeutics Partner to Develop Personalized Cancer Vaccines

BioNTech, UK Government to Expand Access to Personalized mRNA Cancer Vaccines in England

In Brief This Week: Datar Cancer Genetics, Daiichi Sankyo, ProPhase Labs, Innovent Biologics

Frontier Medicines Selects KRAS G12C Inhibitor as Lead Development Candidate

Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer

Nuvectis Partners With ENGOT, GOG Foundation on Phase Ib Ovarian Cancer Trial of HSF1 Inhibitor

Merck Pays $175M Upfront for Rights to Seven Kelun-Biotech Antibody-Drug Conjugate Candidates

Jazz Takes Up Option on Zymeworks' HER2-Targeted Bispecific Antibody

Gilead Sciences to Acquire Cell Therapy Biotech Tmunity Therapeutics

Invectys, CTMC Begin First-in-Human Trial of HLA-G-Targeting CAR T-Cell Therapy in Solid Tumors

Ordaōs, Yatiri Bio Ink Deal to Discover, Develop More Personalized Drugs for AML

Carrick Therapeutics, Menarini Group Studying Samuraciclib With Elacestrant

Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform

Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug